JPMorgan Chase & Co. Has $7.62 Million Stake in Trupanion, Inc. (NASDAQ:TRUP)

JPMorgan Chase & Co. raised its position in Trupanion, Inc. (NASDAQ:TRUP - Free Report) by 458.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 158,099 shares of the financial services provider's stock after purchasing an additional 129,782 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.37% of Trupanion worth $7,620,000 at the end of the most recent quarter.

Other hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. lifted its holdings in shares of Trupanion by 1.3% during the 4th quarter. Vanguard Group Inc. now owns 3,596,725 shares of the financial services provider's stock valued at $173,362,000 after buying an additional 45,653 shares during the last quarter. Fox Run Management L.L.C. acquired a new stake in Trupanion in the fourth quarter valued at approximately $371,000. KLP Kapitalforvaltning AS bought a new stake in Trupanion in the fourth quarter worth approximately $304,000. Sei Investments Co. increased its stake in shares of Trupanion by 36.1% during the 4th quarter. Sei Investments Co. now owns 6,818 shares of the financial services provider's stock worth $329,000 after purchasing an additional 1,810 shares during the last quarter. Finally, American Century Companies Inc. bought a new position in shares of Trupanion during the 4th quarter valued at $1,111,000.

Insider Activity at Trupanion

In other Trupanion news, CEO Margaret Tooth sold 2,294 shares of Trupanion stock in a transaction on Tuesday, March 4th. The shares were sold at an average price of $31.39, for a total transaction of $72,008.66. Following the sale, the chief executive officer now owns 118,784 shares in the company, valued at $3,728,629.76. The trade was a 1.89 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Fawwad Qureshi sold 1,373 shares of the stock in a transaction on Wednesday, February 26th. The shares were sold at an average price of $34.22, for a total transaction of $46,984.06. Following the completion of the transaction, the chief financial officer now owns 2,416 shares of the company's stock, valued at approximately $82,675.52. This represents a 36.24 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 29,792 shares of company stock worth $989,442 over the last three months. Company insiders own 5.50% of the company's stock.

Trupanion Stock Performance

TRUP traded up $0.97 during trading on Tuesday, hitting $34.98. The stock had a trading volume of 588,673 shares, compared to its average volume of 654,419. The firm has a market cap of $1.49 billion, a PE ratio of -152.09, a P/E/G ratio of 6.02 and a beta of 1.66. The company has a current ratio of 1.71, a quick ratio of 1.66 and a debt-to-equity ratio of 0.39. Trupanion, Inc. has a 12 month low of $19.69 and a 12 month high of $57.90. The company has a 50 day simple moving average of $36.18 and a 200-day simple moving average of $45.44.

Trupanion (NASDAQ:TRUP - Get Free Report) last posted its quarterly earnings data on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.06 by ($0.02). The business had revenue of $337.31 million for the quarter, compared to analyst estimates of $335.41 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. Analysts expect that Trupanion, Inc. will post 0.13 EPS for the current year.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on TRUP shares. Piper Sandler decreased their price objective on shares of Trupanion from $57.00 to $52.00 and set an "overweight" rating for the company in a report on Thursday, February 20th. Stifel Nicolaus decreased their price target on Trupanion from $44.00 to $41.00 and set a "hold" rating for the company in a research note on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, four have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $46.60.

About Trupanion

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.